Antiarrhythmic Drug Dosing in Children—Review of the Literature
暂无分享,去创建一个
D. Scherr | S. Kurath-Koller | H. Sallmon | M. Manninger | S. Schweintzger | M. Köstenberger | Nathalie Oeffl | Lukas Schober | Patrick Faudon
[1] I. Sigfusdottir,et al. Effect of the COVID-19 pandemic on adolescent mental health and substance use up to March, 2022, in Iceland: a repeated, cross-sectional, population-based study , 2023, The Lancet Child & Adolescent Health.
[2] M. van Veen,et al. Adverse effect of lockdowns during the COVID-19 pandemic: increased incidence of pediatric crisis admissions due to eating disorders and adolescent intoxications , 2023, European Journal of Pediatrics.
[3] Dirk G. Wilson,et al. Flecainide administration in children: dosage, drug levels, and clinical effect. , 2022, Cardiology in the young.
[4] M. Silka,et al. Ectopic Atrial Tachycardia in Infants Following Congenital Heart Disease Surgery , 2022, Pediatric Cardiology.
[5] A. Amodeo,et al. Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy , 2022, Frontiers in Physiology.
[6] S. Udupa,et al. Ivabradine in the Management of Pediatric Arrhythmias. , 2022, The Canadian journal of cardiology.
[7] F. Kipfmueller,et al. Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension , 2022, ESC heart failure.
[8] C. Fraser,et al. Routine Perioperative Esmolol After Infant Tetralogy of Fallot Repair: Single-Center Retrospective Study of Hemodynamics , 2022, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[9] E. Velázquez-Rodríguez,et al. Idiopathic left fascicular ventricular tachycardia in children and adolescents. , 2022, Boletin medico del Hospital Infantil de Mexico.
[10] P. Postema,et al. Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] H. Horigome,et al. Control of Heart Rate in Infant and Child Tachyarrhythmia With Reduced Cardiac Function Using Landiolol (HEARTFUL) - Results of a Prospective, Multicenter, Uncontrolled Clinical Study. , 2022, Circulation journal : official journal of the Japanese Circulation Society.
[12] F. Drago,et al. Atrial Flutter in Pediatric Patients. , 2022, Cardiac electrophysiology clinics.
[13] Y. Hua,et al. Efficacy and Safety of Various First-Line Therapeutic Strategies for Fetal Tachycardias: A Network Meta-Analysis and Systematic Review , 2022, Frontiers in Pharmacology.
[14] Young Tae Lim,et al. Effective Control of Supraventricular Tachycardia in Neonates May Requires Combination Pharmacologic Therapy , 2022, Journal of clinical medicine.
[15] J. Saul,et al. IV Sotalol Use in Pediatric and Congenital Heart Patients: A Multicenter Registry Study , 2022, Journal of the American Heart Association.
[16] M. Ciabattini,et al. Real-World Use of Carvedilol in Children With Dilated Cardiomyopathy: Long-Term Effect on Survival and Ventricular Function , 2022, Frontiers in Pediatrics.
[17] G. Utine,et al. Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome. , 2022, European journal of medical genetics.
[18] S. Priori,et al. Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers. , 2022, JAMA cardiology.
[19] M. McManus,et al. Supraventricular Tachycardia in Infants With Congenital Diaphragmatic Hernia: Prevalence, Associations, and Outcomes. , 2022, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[20] R. Weber,et al. Antiarrhythmic Medication in Neonates and Infants with Supraventricular Tachycardia , 2022, Pediatric Cardiology.
[21] Gretchen Hackett,et al. Use of ivabradine in a critically ill pediatric patient with recalcitrant ectopic atrial tachycardia and complex congenital heart disease , 2022, HeartRhythm case reports.
[22] R. Crowe,et al. Pediatric Bradycardia Is Undertreated in the Prehospital Setting: A Retrospective Multi-Agency Analysis , 2021, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[23] J. Skinner,et al. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia , 2021, Circulation.
[24] P. Kannankeril,et al. Sotalol vs Amiodarone for Postoperative Junctional Ectopic Tachycardia: Citius, Altius, Fortius? , 2021, Heart Rhythm.
[25] V. Tipo,et al. Ivabradine–Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review , 2021, Pediatric reports.
[26] M. Tzatzarakis,et al. Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review , 2021, Frontiers in Pediatrics.
[27] Bernard Abi-Saleh,et al. Ivabradine: A Potential Therapeutic for Children With Refractory SVT , 2021, Frontiers in Cardiovascular Medicine.
[28] L. Sacconi,et al. The HCN channel as a pharmacological target: Why, where, and how to block it. , 2021, Progress in biophysics and molecular biology.
[29] G. Kaiafa,et al. Propafenone Poisoning of a Female Adolescent After a Suicide Attempt , 2021, Cureus.
[30] A. Kardos,et al. Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome , 2021, European Journal of Pediatrics.
[31] S. Nemoto,et al. Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies , 2021, Pediatric Cardiology.
[32] P. Kahr,et al. “Second line medications” for supraventricular arrhythmias in children: In‐hospital efficacy and adverse events during treatment initiation of sotalol and flecainide , 2021, Journal of cardiovascular electrophysiology.
[33] V. Probst,et al. Dose response to nadolol in congenital Long QT Syndrome. , 2021, Heart rhythm.
[34] F. Hoffmann,et al. European Resuscitation Council Guidelines 2021: Paediatric Life Support. , 2021, Resuscitation.
[35] S. Favilli,et al. Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre , 2021, BMC Cardiovascular Disorders.
[36] S. Kurath-Koller,et al. Holiday heart syndrome: an upcoming tachyarrhythmia in today's youth? , 2021, Cardiology in the young.
[37] Y. Liao,et al. A case report of an infant after episodes of paroxysmal supraventricular tachycardia with left ventricular thrombosis and cerebral infarction. , 2021, Annals of palliative medicine.
[38] N. Blom,et al. The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study , 2021, Pediatric Cardiology.
[39] D. Choi,et al. Ventricular Tachycardia in Association with Propafenone Overdose. , 2021, Acta Cardiologica Sinica.
[40] H. Kafalı,et al. Early postoperative arrhythmias in patients undergoing congenital heart surgery , 2021, Turk gogus kalp damar cerrahisi dergisi.
[41] G. la Marca,et al. Incessant Automatic Atrial Tachycardia in a Neonate Successfully Treated with Nadolol and Closely Spaced Doses of Flecainide: A Case Report , 2020, Pediatric reports.
[42] M. Hazinski,et al. Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. , 2020, Circulation.
[43] F. Morgado,et al. Fascicular tachycardia in a child: striking features that improve emergency management , 2020, BMJ Case Reports.
[44] A. Sabate-Rotes,et al. Flecainide intoxication in pediatric patients with supraventricular tachycardia , 2020, Annals of pediatric cardiology.
[45] O. Aljohani,et al. Intravenous Sotalol in the Young: Safe and Effective Treatment With Standardized Protocols. , 2020, JACC. Clinical electrophysiology.
[46] D. Roden,et al. Atropine-induced sinus tachycardia protects against exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[47] G. Dukic,et al. European , 2020, Definitions.
[48] E. Gaies,et al. Digoxin therapeutic drug monitoring: age influence and adverse events. , 2020, La Tunisie medicale.
[49] A. Lodha,et al. Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis , 2019, Journal of Perinatology.
[50] F. Furlanello,et al. Quinidine-A legacy within the modern era of antiarrhythmic therapy. , 2019, Pharmacological research.
[51] M. Silka,et al. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children , 2019, Pacing and clinical electrophysiology : PACE.
[52] J. Skinner,et al. Fascicular tachycardia in infancy and the use of verapamil: a case series and literature review , 2019, Archives of Disease in Childhood.
[53] L. Bolognese,et al. Brugada Syndrome in the Young and in the Adult: A Tale of 2 Diseases? , 2019, Journal of the American College of Cardiology.
[54] M. Pellegrino,et al. Digoxin‐specific Fab and therapeutic plasma exchange for digitalis intoxication and renal failure , 2019, The American journal of emergency medicine.
[55] Gareth D. K. Matthews,et al. Quinidine Rebooted: Contemporary Approaches to Multichannel Blockade. , 2019, JACC. Clinical electrophysiology.
[56] A. Davis,et al. An Update on the Diagnosis and Management of Catecholaminergic Polymorphic Ventricular Tachycardia. , 2019, Heart, lung & circulation.
[57] J. Moak. Has intravenous sotalol come of age as an alternative treatment for arrhythmias in the young heart? , 2018, Heart rhythm.
[58] V. Tuzcu,et al. Can flecainide totally eliminate bidirectional ventricular tachycardia in pediatric patients with Andersen-Tawil syndrome? , 2018, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[59] C. Rusin,et al. Early experience with intravenous sotalol in children with and without congenital heart disease. , 2018, Heart rhythm.
[60] A. Thiagalingam,et al. The Use of Intravenous Sotalol in Cardiac Arrhythmias. , 2018, Heart, lung & circulation.
[61] M. Nakayashiro,et al. Combined flecainide and sotalol therapy for multifocal atrial tachycardia in cardio‐facio‐cutaneous syndrome , 2018, Pediatrics international : official journal of the Japan Pediatric Society.
[62] L. Liberman,et al. Advanced Heart Block in Children with Lyme Disease , 2018, Pediatric Cardiology.
[63] Lin Wu,et al. Modernized Classification of Cardiac Antiarrhythmic Drugs , 2018, Circulation.
[64] L. Szydlowski,et al. A simplified approach for evaluating sustained slow pathway conduction for diagnosis and treatment of atrioventricular nodal reentry tachycardia in children and adults. , 2018, Advances in medical sciences.
[65] C. McMahon,et al. Successful Treatment of Refractory Cardiac Arrest With β-Blockade and Extracorporeal Life Support in a Pediatric Patient With Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report. , 2018, A&A practice.
[66] Bryan J. Mathis,et al. Landiolol Hydrochloride Rapidly Controls Junctional Ectopic Tachycardia After Pediatric Heart Surgery , 2018, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[67] Jeffrey J. Kim,et al. Intravenous sotalol for the management of postoperative junctional ectopic tachycardia , 2018, HeartRhythm case reports.
[68] J. Walline,et al. Full recovery after prolonged resuscitation from cardiac arrest due to propafenone intoxication , 2018, Medicine.
[69] E. Ozturk,et al. Sustained tachyarrhythmia in children younger than 1 year of age: Six year single‐center experience , 2018, Pediatrics international : official journal of the Japan Pediatric Society.
[70] P. Brugada. Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs. , 2017, Journal of the American College of Cardiology.
[71] K. Takigiku,et al. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial. , 2017, Journal of cardiology.
[72] H. Ge,et al. Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia , 2017, Pediatric Cardiology.
[73] R. Collins,et al. Propranolol Versus Digoxin in the Neonate for Supraventricular Tachycardia (from the Pediatric Health Information System). , 2017, The American journal of cardiology.
[74] Zaixing Yang,et al. Successful treatment of propafenone-induced cardiac arrest by calcium gluconate. , 2017, The American journal of emergency medicine.
[75] D. Bradley,et al. Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children , 2017, Pediatric Cardiology.
[76] D. Atkins,et al. Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[77] J. Skinner,et al. Update on the Diagnosis and Management of Familial Long QT Syndrome. , 2016, Heart, lung & circulation.
[78] P. Brugada,et al. Brugada syndrome in the paediatric population: a comprehensive approach to clinical manifestations, diagnosis, and management , 2016, Cardiology in the Young.
[79] N. Buckley,et al. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1) , 2016, Clinical toxicology.
[80] T. Knilans,et al. Variation in Antiarrhythmic Management of Infants Hospitalized with Supraventricular Tachycardia: A Multi-Institutional Analysis , 2016, Pediatric Cardiology.
[81] S. Priori,et al. Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3 , 2016, Journal of the American College of Cardiology.
[82] Loretta Fala. Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients with Heart Failure. , 2016, American health & drug benefits.
[83] W. Shimizu,et al. Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[84] F. Bosch,et al. Case Report: Hemodynamic Instability Following Severe Metoprolol and Imipramine Intoxication Successfully Treated With Intravenous Fat Emulsion , 2016, American journal of therapeutics.
[85] J. Lerman,et al. Do small doses of atropine (<0.1 mg) cause bradycardia in young children? , 2015, Archives of Disease in Childhood.
[86] E. Karakoç,et al. Role of intravenous lipid emulsions in the management of calcium channel blocker and β-blocker overdose: 3 years experience of a university hospital , 2015, Postgraduate medicine.
[87] T. Potpara,et al. How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[88] A. Moss,et al. Efficacy of different beta-blockers in the treatment of long QT syndrome. , 2014, Journal of the American College of Cardiology.
[89] A. M. Herskind,et al. [Digoxin intoxication in an infant because of confusion of bottles of magistral preparations of medicine]. , 2014, Ugeskrift for laeger.
[90] P. Kubuš,et al. Electrophysiologic Profile and Results of Invasive Risk Stratification in Asymptomatic Children and Adolescents With the Wolff–Parkinson–White Electrocardiographic Pattern , 2014, Circulation. Arrhythmia and electrophysiology.
[91] Jeffrey J. Kim,et al. Race Contributes to Beta-Blocker Efficacy in Pediatric Patients With Arrhythmias , 2014, Pediatric Cardiology.
[92] R. Berg,et al. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation. , 2014, Resuscitation.
[93] S. Poelzing,et al. Combined inhibition of Na⁺ and Ca²⁺ channels: a novel paradigm for the treatment of incessant ventricular arrhythmias in Andersen-Tawil syndrome. , 2014, Heart rhythm.
[94] P. Brugada,et al. The challenges of performing ajmaline challenge in children with suspected Brugada syndrome , 2014, Open Heart.
[95] B. Meibohm,et al. Pharmacokinetics of intravenous amiodarone in children , 2013, Archives of Disease in Childhood.
[96] É. Marijon,et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[97] F. Vernuccio,et al. Role of Bisoprolol in Patients with Long QT Syndrome , 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[98] M. Peters,et al. The Effect of Atropine on Rhythm and Conduction Disturbances During 322 Critical Care Intubations* , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[99] M. Dick,et al. Verapamil in Infants: An Exaggerated Fear? , 2013, Pediatric Cardiology.
[100] İ. Ece,et al. Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy , 2013, Medical science monitor : international medical journal of experimental and clinical research.
[101] D. Wiest,et al. Clinical Pharmacokinetics and Therapeutic Efficacy of Esmolol , 2012, Clinical Pharmacokinetics.
[102] R. Hauer,et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.
[103] A. M. Sheikh,et al. Optimal dose of adenosine effective for supraventricular tachycardia in children. , 2012, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[104] P. Brugada,et al. Ajmaline Challenge in Young Individuals with Suspected Brugada Syndrome , 2011, Pacing and clinical electrophysiology : PACE.
[105] K. Hill. European Resuscitation Council Guidelines (2010) , 2011 .
[106] J. Saul,et al. The Pharmacokinetics of Esmolol in Pediatric Subjects with Supraventricular Arrhythmias , 2006, Pediatric Cardiology.
[107] J. Triedman,et al. Intravenous Amiodarone for Incessant Tachyarrhythmias in Children: A Randomized, Double-Blind, Antiarrhythmic Drug Trial , 2005, Circulation.
[108] S. Etheridge,et al. QT dispersion after beta-blocker therapy (carvedilol or metoprolol) in children with heart failure. , 2003, The American journal of cardiology.
[109] C. Narasimhan,et al. Refractory adenosine-sensitive congenital His bundle tachycardia: response to calcium-channel blockers. , 2003, Indian heart journal.
[110] R. Pass,et al. Continuous intravenous diltiazem infusion for short-term ventricular rate control in children. , 2000, The American journal of cardiology.
[111] W. Allan,et al. Long QT Syndrome , 1998, Pediatrics.
[112] Y. Hirota,et al. Effect of beta-blocker treatment in dilated cardiomyopathy with bradyarrhythmias. , 1998, Japanese circulation journal.
[113] A. Garson,et al. Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. , 1990, Journal of the American College of Cardiology.
[114] N. Mostow,et al. A general overview of amiodarone toxicity: its prevention, detection, and management. , 1989, Progress in cardiovascular diseases.
[115] H. Fujino,et al. [Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children]. , 1989, Journal of cardiology.
[116] S. Etheridge,et al. A personalized approach to long QT syndrome , 2019, Current opinion in cardiology.
[117] M. Gold,et al. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? , 2017, Heart rhythm.
[118] Amy N. McCammond,et al. Belhassen tachycardia in a 19-month-old child. , 2015, The Journal of pediatrics.
[119] M. Romanò. Inherited Cardiac Arrhythmias , 2015 .
[120] Karly P Garnock-jones. Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension. , 2012, Drugs.
[121] T. Matsumura,et al. Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. , 2010, Internal medicine.
[122] I. Ostman-Smith. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death. , 2010, Fundamental & clinical pharmacology.